Discontinued — last reported Q3 '25
Johnson & Johnson Shares (Diluted) increased by 0.4% to 2.4B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 0.0%, from 2.4B to 2.4B. This increase may warrant attention — for this metric, lower values are generally preferred.
A significant increase relative to basic shares indicates a high level of employee stock compensation or outstanding convertible debt.
The total number of shares that would be outstanding if all 'in-the-money' options, warrants, and convertible instrument...
Investors compare this to the basic share count to assess how much current ownership might be 'watered down' by future share issuances.
is_weighted_shares_diluted| Q2 '21 | Q3 '21 | Q4 '21 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B | 2.6B | 2.5B | 2.4B | 2.4B | 2.4B | 2.4B | 2.4B | 2.4B |
| QoQ Change | — | -0.0% | +0.1% | -0.3% | +0.1% | -0.2% | -2.1% | -2.1% | -4.7% | -0.3% | +0.2% | -0.2% | -0.2% | +0.4% |
| YoY Change | — | — | — | -0.2% | -0.1% | -0.5% | -2.3% | -4.4% | — | -7.0% | -4.8% | -0.3% | -0.1% | +0.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.